These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6124989)

  • 1. Co-dergocrine (hydergine) in the treatment of tardive dyskinesia.
    Rastogi SC; Blowers AJ; Gibson AC
    Psychol Med; 1982 May; 12(2):427-9. PubMed ID: 6124989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Co-dergocrine mesylate on tardive dyskinesia. A preliminary report.
    Hajioff J; Wallace M
    Psychopharmacology (Berl); 1983; 79(1):1-3. PubMed ID: 6403956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tardive dyskinesia with dihydrogenated ergot alkaloids (hydergine): a pilot study.
    Mohamed SN; Kazarian S; Merskey H; Thompson MG
    Can J Psychiatry; 1980 Jun; 25(4):325-8. PubMed ID: 6103748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
    Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
    Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Hydergine on platelet deposition on "active" human carotid artery lesions and platelet function.
    Steurer G; Fitscha P; Ettl K; Sinzinger H
    Thromb Res; 1989 Sep; 55(5):577-89. PubMed ID: 2814944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of oxypertine in tardive dyskinesia.
    Freeman HL; Soni SD; Carpenter L
    Int Pharmacopsychiatry; 1980; 15(5):281-91. PubMed ID: 6114934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonazepam and phenobarbital in tardive dyskinesia.
    Bobruff A; Gardos G; Tarsy D; Rapkin RM; Cole JO; Moore P
    Am J Psychiatry; 1981 Feb; 138(2):189-93. PubMed ID: 6109454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial.
    Loonen AJ; Verwey HA; Roels PR; van Bavel LP; Doorschot CH
    J Clin Psychopharmacol; 1992 Feb; 12(1):39-42. PubMed ID: 1348061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
    Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tardive dyskinesia with vitamin E.
    Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
    Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
    Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
    J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of tardive dyskinesia with baclofen.
    Glazer WM; Moore DC; Bowers MB; Bunney BS; Roffman M
    Psychopharmacology (Berl); 1985; 87(4):480-3. PubMed ID: 3936106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study.
    Matsunaga T; Ohyama S; Takehara S; Kabashima K; Moriyama S; Tsuzuki J; Ikeda H; Suematsu M; Akizuki K; Fujimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):533-9. PubMed ID: 3043555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial.
    Emsley R; Niehaus DJ; Koen L; Oosthuizen PP; Turner HJ; Carey P; van Rensburg SJ; Maritz JS; Murck H
    Schizophr Res; 2006 May; 84(1):112-20. PubMed ID: 16632329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin E in the treatment of tardive dyskinesia.
    Akhtar S; Jajor TR; Kumar S
    J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.